Kansai Nerolac Reports Strong Revenue Growth in Q2

Kansai Nerolac Paints reported a consolidated revenue of Rs 2317.38 crore for the second quarter, alongside a profit after tax of Rs 143.99 crore.

Reader Takeaway: Revenue grew across core segments, but investors must monitor margin pressures from raw material and currency volatility.

What just happened

Kansai Nerolac released its financial results for the second quarter of FY2027. The company officially integrated the financials of its wholly-owned subsidiary, Nerofix Private Limited, following an NCLT order. This amalgamation is accounted for using the pooling of interest method, with results restated retrospectively from April 1, 2025, to provide a normalized performance view.

Why this matters

The restated figures offer a clearer picture of the combined entity's health. With consolidated revenue climbing to Rs 2317.38 crore from Rs 1954.18 crore in the year-ago period, the company demonstrates healthy expansion. Both the Decorative and Industrial segments contributed to this momentum, with the latter benefiting from long-standing customer relationships.

The backstory

The company has been working to expand its footprint beyond traditional paints into high-growth adjacencies like construction chemicals, waterproofing, and wood finishes. This strategy aims to capture a larger share of the infrastructure and renovation markets, which remain key drivers for the decorative paint division.

Risks to watch

Management has identified raw material price fluctuations and foreign exchange volatility as significant headwinds. These factors continue to exert pressure on input costs. To counter this, the company is implementing calibrated pricing strategies, sourcing efficiencies, and formulation optimizations to protect margins.

What to track next

Investors should closely watch the management's ability to navigate the competitive landscape while maintaining profitability. Further updates on the integration of Nerofix and the impact of the festive season on paint demand in the coming quarters will be critical for assessing sustained margin health.